Provider
          HIMSS23
          
      
                    
            
  Dana Trampas, senior digital health specialist at HIMSS, shares how healthcare organizations can promote and advocate for LGBTQ health equity and inclusion within their patient populations and their workforces.
        
        
          
          HIMSS23
          
      
                    
            
  Natasha Ramontal, HIMSS digital health strategist for community outcomes and analytics, describes how the Community Care Outcomes Maturity Model (C-COMM) engages and empowers patients by supporting meaningful care relationships.
        
        
          The company says its LLM has passed over 100 healthcare certifications and surpassed GPT-4 and other commercial models’ performance.
        
        
          Eligible Aetna commercial members will be able to access virtual visits with Gennev's doctors and dietitians without prior authorization.
        
        
          
          HIMSS23
          
      
                    
            
  Lawrence Voyten, HIMSS board member and national advocacy chair, details how HIMSS chapter leaders can proactively support health equity and interoperability with their local governments.
        
        
          Webex by Cisco will integrate Voiceitt's technology into its platform for people with non-standard speech to be easily understood during virtual calls. 
        
        
          Video game-based therapeutic company Akili and baby tech company Owlet also post first quarter results.
        
        
          
          HIMSS23
          
      
                    
            
  Lawrence Whittle, CCO at Verana Health, describes how patient data can be used to improve healthcare, including making clinical trials more efficient and helping clinicians discover which treatments yield the most value.
        
        
          The California-based company will use the investment to scale product innovation and advance integrations with enterprise partners.
        
        
          
          HIMSS23
          
      
                    
            
  Dr. John Showalter, CPO at Linus Health, describes drug therapy advances for Alzheimer's and how technology can help screen and identify at-risk patients sooner to optimize outcomes and quality of life.
        
        
           
 
 
 
 
 
